Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel Liposome Plus S-1 as Neoadjuvant Chemotherapy for Advanced Gastric Cancer
NCT02163291Phase 2Unknown
- Sponsor
- Peking University
- Start
- Dec 2013
- Primary completion
- Dec 2014
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 2 trial of liposomal paclitaxel in gastric cancer (GC), sponsored by Peking University. Status: unknown.
02
Drugs
liposomal paclitaxel
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT02163291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02163291.